British pharmaceutical company GSK on Wednesday said it swung into a net loss in the third quarter after settling lawsuits in the United States surrounding its Zantac heartburn drug. GSK suffered ...

GSK said total sales fell by two per cent in the third quarter Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed guidance and ...

GSK (GSK) used its third-quarter trading update to draw a definitive line under the damaging litigation around its now discontinued heartburn medicine Zantac, by agreeing a settlement earlier in ...

Pharmaceutical giant GSK has reported a drop in profit due to charges related to the Zantac lawsuits but has reaffirmed ...

Shares in GSK fell around 9% this morning after a judge in a Delaware court gave the green light for tens of thousands of lawsuits claiming harm by gastrointestinal drug Zantac to proceed to trial.

GSK and other drugmakers have lost no time in filing an appeal to a Delaware court’s decision to allow more than 70,000 Zantac-related lawsuits to go ahead. Just over a week ago, Judge Vivian ...

Read more about our Product Review Guidelines here. Amp ($1,795) is the newest addition to the world of smart fitness equipment, and it's unlike anything I've tried before. At first glance ...

His oral medications prior to admission included topiramate 100 mg twice daily, ranitidine hydrochloride 75 mg twice daily, ferrous sulfate 325 mg twice daily, potassium chloride 10 meq once daily ...

As you may no doubt guess, this little amp was created in collaboration with legendary guitarist Steve Vai, and while it's not as crazy as his multi-headed Hydra guitar, the Spark Mini Vai is ...

Learn More The AMP Ltd (ASX: AMP) share price is surging higher today. Shares in the S&P/ASX 200 Index (ASX: XJO) financial services company closed yesterday trading for $1.355. In morning trade ...

The EX Series features two audiophile-grade hi-fi components: the EXN100 music streamer ($1,799) and the EXA100 integrated amplifier ($2,199). The latter is most exciting. Not only are integrated ...

Pharmaceutical titan GSK has witnessed a profit tumble owing to charges linked with the litigation over Zantac, yet has reiterated its financial forecasts, stressing stability in the company's core ...